NTRB

Nutriband Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$5.97

Price (1 Year)

$8.13 $2.85

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %0.3 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %3.6 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain.

Website

Analysis (Turkish): NTRB Hissesi Caiz mi, Helal mi? Nutriband Inc. Katılım Analizi